Matrix remodeling during endochondral ossification

Trends in Cell Biology

Volumn 14, Issue 2, 2004, Pages 86-93

  Ortega, Nathalie ^a   Behonick, Danielle J ^a   Werb, Zena ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE 3; GELATINASE B; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; REGULATOR PROTEIN; STROMELYSIN; STROMELYSIN 2; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TISSUE INHIBITOR OF METALLOPROTEINASE 4;

BONE MATRIX; BONE REMODELING; CARTILAGE CELL; CELL HYPERPLASIA; CELL PROLIFERATION; ENCHONDRAL OSSIFICATION; EXPERIMENTAL MOUSE; EXTRACELLULAR MATRIX; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0442276482     PISSN: 09628924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcb.2003.12.003     Document Type: Review

References (58)

1. Karsenty G., Wagner E.F. Reaching a genetic and molecular understanding of skeletal development. Dev. Cell. 2:2002;389-406.
2. Costell M., et al. Perlecan maintains the integrity of cartilage and some basement membranes. J. Cell Biol. 147:1999;1109-1122.
3. Arikawa-Hirasawa E., et al. Perlecan is essential for cartilage and cephalic development. Nat. Genet. 23:1999;354-358.
4. Jacenko O., et al. A dominant interference collagen X mutation disrupts hypertrophic chondrocyte pericellular matrix and glycosaminoglycan and proteoglycan distribution in transgenic mice. Am. J. Pathol. 159:2001;2257-2269.
5. Blair H.C., et al. Mechanisms balancing skeletal matrix synthesis and degradation. Biochem. J. 364:2002;329-341.
6. Egeblad M., Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer. 2:2002;161-174.
7. Vu T.H., et al. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell. 93:1998;411-422.
8. Holmbeck K., et al. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell. 99:1999;81-92.
9. Zhou Z., et al. Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. Proc. Natl. Acad. Sci. U. S. A. 97:2000;4052-4057.
10. Van Wart H.E., Birkedal-Hansen H. The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc. Natl. Acad. Sci. U. S. A. 87:1990;5578-5582.
11. Sato H., et al. Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2. FEBS Lett. 393:1996;101-104.
12. Yasui N., et al. Production of collagenase inhibitor by the growth cartilage of embryonic chick bone: isolation and partial characterization. Coll. Relat. Res. 1:1981;59-72.
13. Dean D.D., et al. Localization of collagenase in the growth plate of rachitic rats. J. Clin. Invest. 76:1985;716-722.
14. Brown C.C., et al. Immunolocalization of metalloproteinases and their inhibitor in the rabbit growth plate. J. Bone Joint Surg. Am. 71:1989;580-593.
15. Flenniken A.M., Williams B.R. Developmental expression of the endogenous TIMP gene and a TIMP-lacZ fusion gene in transgenic mice. Genes Dev. 4:1990;1094-1106.
16. Apte S.S., et al. The matrix metalloproteinase-14 (MMP-14) gene is structurally distinct from other MMP genes and is co-expressed with the TIMP-2 gene during mouse embryogenesis. J. Biol. Chem. 272:1997;25511-25517.
17. Zeng Y., et al. Temporal and spatial regulation of gene expression mediated by the promoter for the human tissue inhibitor of metalloproteinases-3 (TIMP-3)-encoding gene. Dev. Dyn. 211:1998;228-237.
18. Airola K., et al. Human TIMP-3 is expressed during fetal development, hair growth cycle, and cancer progression. J. Histochem. Cytochem. 46:1998;437-447.
19. Bord S., et al. Tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) distribution in normal and pathological human bone. Bone. 24:1999;229-235.
20. Huang W., et al. Tissue inhibitor of metalloproteinases-4 (TIMP-4) gene expression is increased in human osteoarthritic femoral head cartilage. J. Cell. Biochem. 85:2002;295-303.
21. Bord S., et al. Stromelysin-1 (MMP-3) and stromelysin-2 (MMP-10) expression in developing human bone: potential roles in skeletal development. Bone. 23:1998;7-12.
22. Mattot V., et al. Expression of interstitial collagenase is restricted to skeletal tissue during mouse embryogenesis. J. Cell Sci. 108:1995;529-535.
23. Gack S., et al. Expression of interstitial collagenase during skeletal development of the mouse is restricted to osteoblast-like cells and hypertrophic chondrocytes. Cell Growth Differ. 6:1995;759-767.
24. Tuckermann J.P., et al. Collagenase-3 (MMP-13) and integral membrane protein 2a (Itm2a) are marker genes of chondrogenic/osteoblastic cells in bone formation: sequential temporal, and spatial expression of Itm2a, alkaline phosphatase, MMP-13, and osteocalcin in the mouse. J. Bone Miner. Res. 15:2000;1257-1265.
25. Hayami T., et al. Spatiotemporal change of rat collagenase (MMP-13) mRNA expression in the development of the rat femoral neck. J. Bone Miner. Metab. 18:2000;185-193.
26. Stahle-Backdahl M., et al. Collagenase-3 (MMP-13) is expressed during human fetal ossification and re-expressed in postnatal bone remodeling and in rheumatoid arthritis. Lab. Invest. 76:1997;717-728.
27. Johansson N., et al. Collagenase-3 (MMP-13) is expressed by hypertrophic chondrocytes, periosteal cells, and osteoblasts during human fetal bone development. Dev. Dyn. 208:1997;387-397.
28. Davoli M.A., et al. Enzymes active in the areas undergoing cartilage resorption during the development of the secondary ossification center in the tibiae of rats aged 0-21 days: II. Two proteinases, gelatinase B and collagenase-3, are implicated in the lysis of collagen fibrils. Dev. Dyn. 222:2001;71-88.
29. Jimenez M.J., et al. Collagenase 3 is a target of Cbfa1, a transcription factor of the runt gene family involved in bone formation. Mol. Cell. Biol. 19:1999;4431-4442.
30. Uusitalo H., et al. Expression of cathepsins B, H, K, L, and S and matrix metalloproteinases 9 and 13 during chondrocyte hypertrophy and endochondral ossification in mouse fracture callus. Calcif. Tissue Int. 67:2000;382-390.
31. Reponen P., et al. High expression of 92-kD type IV collagenase (gelatinase B) in the osteoclast lineage during mouse development. J. Cell Biol. 124:1994;1091-1102.
32. Blavier L., Delaisse J.M. Matrix metalloproteinases are obligatory for the migration of preosteoclasts to the developing marrow cavity of primitive long bones. J. Cell Sci. 108:1995;3649-3659.
33. Lee E.R., et al. Active gelatinase B is identified by histozymography in the cartilage resorption sites of developing long bones. Dev. Dyn. 215:1999;190-205.
34. Gustafsson E., et al. Role of collagen type II and perlecan in skeletal development. Ann. N. Y. Acad. Sci. 995:2003;140-150.
35. Martignetti J.A., et al. Mutation of the matrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome. Nat. Genet. 28:2001;261-265.
36. Itoh T., et al. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res. 58:1998;1048-1051.
37. Kinoh H., et al. MT-MMP, the cell surface activator of proMMP-2 (pro-gelatinase A), is expressed with its substrate in mouse tissue during embryogenesis. J. Cell Sci. 109:1996;953-959.
38. Sato T., et al. Identification of the membrane-type matrix metalloproteinase MT1-MMP in osteoclasts. J. Cell Sci. 110:1997;589-596.
39. Blavier L., DeClerck Y.A. Tissue inhibitor of metalloproteinases-2 is expressed in the interstitial matrix in adult mouse organs and during embryonic development. Mol. Biol. Cell. 8:1997;1513-1527.
40. Joronen K., et al. Temporospatial expression of tissue inhibitors of matrix metalloproteinases-1, -2 and -3 during development, growth and aging of the mouse skeleton. Histochem. Cell Biol. 114:2000;157-165.
41. Dew G., et al. Localisation of matrix metalloproteinases and TIMP-2 in resorbing mouse bone. Cell Tissue Res. 299:2000;385-394.
42. Engsig M.T., et al. Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J. Cell Biol. 151:2000;879-889.
43. Zelzer E., et al. Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2. Mech. Dev. 106:2001;97-106.
44. Ivkovic S., et al. Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development. 130:2003;2779-2791.
45. Gerber H.P., et al. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat. Med. 5:1999;623-628.
46. Maes C., et al. Impaired angiogenesis and endochondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Mech. Dev. 111:2002;61-73.
47. Zelzer E., et al. Skeletal defects in VEGF(120/120) mice reveal multiple roles for VEGF in skeletogenesis. Development. 129:2002;1893-1904.
48. Ivkovic S., et al. Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development. 130:2003;2779-2791.
49. Colnot C., et al. Altered fracture repair in the absence of MMP9. Development. 130:2003;4123-4133.
50. Heissig B., et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell. 109:2002;625-637.
51. Zhao W., et al. Osteocyte and osteoblast apoptosis and excessive bone deposition accompany failure of collagenase cleavage of collagen. J. Clin. Invest. 106:2000;941-949.
52. Karsdal M.A., et al. Matrix metalloproteinase-dependent activation of latent transforming growth factor-beta controls the conversion of osteoblasts into osteocytes by blocking osteoblast apoptosis. J. Biol. Chem. 277:2002;44061-44067.
53. Serra R., et al. Parathyroid hormone-related peptide (PTHrP)-dependent and -independent effects of transforming growth factor beta (TGF-beta) on endochondral bone formation. J. Cell Biol. 145:1999;783-794.
54. Lanske B., et al. PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth. Science. 273:1996;663-666.
55. Vortkamp A., et al. Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science. 273:1996;613-622.
56. Bergers G., et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell Biol. 2:2000;737-744.
57. Yu Q., et al. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev. 14:2000;163-176.
58. Adams C.S., et al. Matrix regulation of skeletal cell apoptosis. Role of calcium and phosphate ions. J. Biol. Chem. 276:2001;20316-20322.